Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

GRAS Notices
  • Print
  • Share
  • E-mail
-

GRN No. 1207

Brazzein preparation produced by Aspergillus oryzae 90402 expressing a gene encoding for brazzein from Pentadiplandra brazzeana

Intended Use: Intended for use as a sweetener in foods generally at levels consistent with good manufacturing practices.
Basis: Scientific procedures
Notifier: Nanjing Bestzyme Bio-Engineering Co. Ltd.
Notifier Address: No. 28 Yongxi Rd
Jiangning District, Nanjing, Jiangsu Province
China
GRAS Notice (releasable information): GRN 1207 with amendments (in PDF) (2.8 MB)
Date of closure: Apr 10, 2025
Date of FDA’s corrected letter: May 23, 2025
FDA's Letter: FDA has no questions (in PDF) (234 kB)
Additional correspondence: May 23, 2025
Correction Letter (in PDF) (89 kB)
-
-